Lifecore Biomedical (LFCR) Institutional Ownership → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free LFCR Stock Alerts $5.84 +0.06 (+1.04%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lifecore Biomedical (NASDAQ:LFCR)CurrentInstitutional OwnershipPercentage83.36%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$33.49MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$13.20M Get LFCR Insider Trade Alerts Want to know when executives and insiders are buying or selling Lifecore Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LFCR Institutional Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Lifecore Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/28/2024 Boston Partners19,674$104K0.0%N/A0.065% 5/10/2024 Vanguard Group Inc.1,184,856$6.29M0.0%-12.3%3.908% 5/10/2024 Tocqueville Asset Management L.P.351,700$1.87M0.0%-12.4%1.160% 5/9/2024 State Board of Administration of Florida Retirement System21,544$114K0.0%N/A0.071% 5/7/2024 Cove Street Capital LLC1,283,780$6.82M2.2%+41.0%4.234% 5/7/2024 Oppenheimer Asset Management Inc.43,001$228K0.0%+79.9%0.142% Get the Latest News and Ratings for LFCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. 5/7/2024 SG Americas Securities LLC10,659$57K0.0%N/A0.035% 5/1/2024 Mirae Asset Global Investments Co. Ltd.10,860$58K0.0%N/A0.036% 4/30/2024 Cutter & CO Brokerage Inc.10,767$57K0.0%-30.8%0.036% 2/15/2024 Greenhaven Road Investment Management L.P.2,366,956$14.65M6.6%+7.9%7.806% 2/14/2024 Visionary Wealth Advisors497,204$3.08M0.2%-0.8%1.640% 2/13/2024 DCF Advisers LLC259,684$1.61M0.9%+115.1%0.856% 2/12/2024 Cove Street Capital LLC910,264$5.64M1.7%-17.7%3.002% 2/1/2024 Cutter & CO Brokerage Inc.15,567$96K0.0%-28.3%0.051% 1/30/2024 Keene & Associates Inc.21,935$136K0.1%-8.4%0.072% 12/6/2023 Citigroup Inc.33,618$254K0.0%+2,311.6%0.111% 11/21/2023 Greenhaven Road Investment Management L.P.2,193,333$16.55M8.4%+15.3%7.234% 11/14/2023 Trexquant Investment LP47,157$356K0.0%N/A0.156% 11/13/2023 Visionary Wealth Advisors501,334$3.78M0.3%+0.4%1.653% 11/9/2023 HAP Trading LLC163,773$1.24M0.2%-82.6%0.540% 11/9/2023 Cove Street Capital LLC1,105,556$8.35M2.8%-31.7%3.646% 11/9/2023 Tocqueville Asset Management L.P.401,700$3.03M0.1%-11.1%1.325% 11/8/2023 Oppenheimer Asset Management Inc.33,532$253K0.0%-48.4%0.111% 11/7/2023 Barclays PLC30,911$233K0.0%+244.8%0.102% 11/7/2023 Jump Financial LLC36,918$279K0.0%N/A0.122% 11/6/2023 Assenagon Asset Management S.A.23,852$180K0.0%-68.4%0.079% 10/24/2023 Bank of New York Mellon Corp24,615$186K0.0%-7.9%0.081% 9/21/2023 Barclays PLC8,965$87K0.0%N/A0.030% 8/15/2023 Corsair Capital Management L.P.122,431$1.18M0.4%N/A0.404% 8/11/2023 Cove Street Capital LLC1,619,536$15.66M4.9%N/A5.341% 8/11/2023 Visionary Wealth Advisors499,309$4.83M0.4%N/A1.647% 8/10/2023 Gamco Investors INC. ET AL76,500$740K0.0%N/A0.252% 8/10/2023 Gabelli Funds LLC16,600$161K0.0%N/A0.055% 8/7/2023 Mirabella Financial Services LLP15,413$149K0.0%N/A0.051% 8/3/2023 Oppenheimer Asset Management Inc.64,975$628K0.0%N/A0.214% 8/1/2023 Cutter & CO Brokerage Inc.21,700$210K0.1%N/A0.072% 7/26/2023 Keene & Associates Inc.24,100$233K0.2%N/A0.079% 7/25/2023 Assenagon Asset Management S.A.75,391$729K0.0%N/A0.249% 7/18/2023 Defender Capital LLC.86,450$836K0.3%N/A0.285% 7/18/2023 Diversified Trust Co46,062$445K0.0%N/A0.152% Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.6/1/2023 Prelude Capital Management LLC21,295$80K0.0%N/A0.070% (Data available from 1/1/2016 forward) LFCR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LFCR shares? During the previous two years, 27 institutional investors and hedge funds held shares of Lifecore Biomedical. The most heavily invested institutionals were Greenhaven Road Investment Management L.P. ($14.65M), Cove Street Capital LLC ($6.82M), Vanguard Group Inc. ($6.29M), Visionary Wealth Advisors ($3.08M), Tocqueville Asset Management L.P. ($1.87M), DCF Advisers LLC ($1.61M), and HAP Trading LLC ($1.24M).Learn more on LFCR's institutional investors. What percentage of Lifecore Biomedical stock is owned by institutional investors? 83.36% of Lifecore Biomedical stock is owned by institutional investors. Learn more on LFCR's institutional investor holdings. Which institutional investors have been buying Lifecore Biomedical stock? Of the 23 institutional investors that purchased Lifecore Biomedical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cove Street Capital LLC ($1.99M), Visionary Wealth Advisors ($501.33K), Greenhaven Road Investment Management L.P. ($464.32K), DCF Advisers LLC ($138.93K), Corsair Capital Management L.P. ($122.43K), Defender Capital LLC. ($86.45K), and Oppenheimer Asset Management Inc. ($84.07K). How much institutional buying is happening at Lifecore Biomedical? Institutional investors have bought a total of 3,897,591 shares in the last 24 months. This purchase volume represents approximately $33.58M in transactions. Which Lifecore Biomedical major shareholders have been selling company stock? Of the 10 institutional investors that sold Lifecore Biomedical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: HAP Trading LLC ($775.53K), Cove Street Capital LLC ($709.27K), Vanguard Group Inc. ($165.71K), Tocqueville Asset Management L.P. ($100K), Assenagon Asset Management S.A. ($51.54K), Oppenheimer Asset Management Inc. ($31.44K), and Cutter & CO Brokerage Inc. ($10.93K). How much institutional selling is happening at Lifecore Biomedical? Institutional investors have sold a total of 1,852,660 shares in the last 24 months. This volume of shares sold represents approximately $13.20M in transactions. Related Companies: American Vanguard Institutional Ownership Seneca Foods Institutional Ownership Oil-Dri Co. of America Institutional Ownership Silence Therapeutics Institutional Ownership Harrow Institutional Ownership ALX Oncology Institutional Ownership Dianthus Therapeutics Institutional Ownership AnaptysBio Institutional Ownership ArriVent BioPharma Institutional Ownership Arbutus Biopharma Institutional Ownership This page (NASDAQ:LFCR) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.